Review of Cervical Cancer Preventive and Screening Strategies in India
Cervical cancer (CC) rapidly spread in the women. CC is the cancer which start from the cervix this is the 1st stage and 3rd most common type cancer in women’s worldwide. Continuously, Human papillomavirus (HPV) infection is the higher&strongest epidemiologic risk factor for CC.HPV-16 and HPV-18, these are type virus with high-risk HPV types. But at present many types of techniques available as – Pap smear test, Colposcopy, HPV virus test/detection, Visual inspection of cervix with 5% acetic acid, and Visual inspection of cervix with Lugol’s Iodine.The majority of diagnosis with CC will be analyzed more than 13000 and rate of death 4000 with women in United States and it also deadline disease in India. It is one of the cancer which is preventable. This article studied with in PubMed and Google scholar, studies about cervical cancer from Wikipedia and you-tube also. And it is only meta-analysis or multi-institutional, review article and research studies were considered for analysis of cervical cancer. The most important risk factor is determined with human beings Human papillomavirus (HPV) which traditional in worldwide. This is the type of cancer which is screening and detect in the early stage by the screening methods. In this article, abstracted published studies about to year between during 1995-2018 which has been carried out in worldwide on CC with significance on screening test methods. Basically, Pap smear is the method of screening for cytology but now a day many studies have been accomplish to investigate different methods as well as visual inspection method.
Keywords: Cervical Cancer screening, HPV, Screening methods, Pap Smear test, India United State.
2. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. Journal of clinical pathology. 2002; 55(4):244-65.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of pathology. 1999; 189(1):12-9.
4. Jacob M, Mawar N, Menezes L, Kaipilyawar S, Gandhi S, Khan I, Patki M, Bingham A, LaMontagne DS, Bagul R, Katendra T. Assessing the environment for introduction of human papillomavirus vaccine in India. The Open Vaccine Journal. 2010; 3(1).
5. Madhivanan P, Krupp K, Yashodha MN, Marlow L, Klausner JD, Reingold AL. Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India. Vaccine. 2009; 27(38):5203-8.
6. Takiar R, Srivastav A. Time Trend in Breast and Cervix Cancer of Women in India–. Asian Pacific Journal of Cancer Prevention. 2008; 9:777-80.
7. Patro BK, Nongkynrih B. Review of screening and preventive strategies for cervical cancer in India. Indian journal of public health. 2007; 51(4):216.
8. Patro BK, Nongkynrih B. Review of screening and preventive strategies for cervical cancer in India. Indian journal of public health. 2007; 51(4):216.
9. Jussawalla DJ, Yeole BB. Epidemiology of cancer of the cervix in greater Bombay. Journal of surgical oncology. 1984; 26(1):53-62.
10. Das RK, DGO M. Cancer cervix in Assam. J ObstetGynaecol India. 1970; 20:234-9.
11. Dutta PK, Upadhyay A, Dutta M, Urmil AC, Thergaonkar MP, Ganguly SS. A case control study of cancer cervix patients attending Command Hospital, Pune. Indian journal of cancer. 1990; 27(2):101-8.
12. Mishra NK, Sinha TK. Cytologic screening for the detection of cancer in the uterine cervix—a survey in Patna (India). Cancer letters. 1990 30; 52(1):21-7.
13. Varghese C, Amma NS, Chitrathara K, Dhakad N, Rani P, Malathy L, Nair MK. Risk factors for cervical dysplasia in Kerala, India. Bulletin of the world Health organization. 1999; 77(3):281.
14. Nandakumar A, Gupta PC, Gangadharan P, Visweswara RN, Parkin DM. Geographic pathology revisited: development of an atlas of cancer in India. International journal of cancer. 2005; 116(5):740-54.
15. Zendehdel K. Cancer statistics in IR Iran in 2018. Basic & Clinical Cancer Research. 2019; 11(1):1-4.
16. Melikian AA, Sun P, Prokopczyk B, El-Bayoumy K, Hoffmann D, Wang X, Waggoner S. Identification of benzo [a] pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. Cancer letters. 1999; 146(2):127-34.
17. Prokopczyk B, Cox JE, Hoffmann D, Steven E SE. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. Journal of the National Cancer Institute. 1997; 89(12):868-73.
18. Alam S, Conway MJ, Chen HS, Meyers C. The cigarette smoke carcinogen benzo [a] pyrene enhances human papillomavirus synthesis. Journal of virology. 2008 Jan 15; 82(2):1053-8.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).